Home / Ionis Pharmaceuticals INC (IONS) / donidalorsen
Forward catalyst · IONS

donidalorsen

Sponsor Ionis Pharmaceuticals INC · listed as IONS

READOUT Phase 3 Confidence: medium Source: clinicaltrials

Next catalyst

Event typeREADOUT
Expected date2026-12-31
As disclosedDec 2026
Date precisionmonth
Confidencemedium
Verify at source →

Trial & sponsor

Trial (NCT)NCT05392114
PhasePHASE3
StatusACTIVE_NOT_RECRUITING
Lead sponsorIonis Pharmaceuticals, Inc.
Listed asIONS
Condition(s)Hereditary Angioedema
!

Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.

This is one row of the free CSA sample. The full snapshot carries 2,103 forward catalysts across 139 listed sponsors.

Get the full dataset — $499 →   More IONS catalysts